🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of hepatic...
Status
Unknown
Location
Dongguan People's Hospital
Start Date
2018-03-09
Trial ID
NCT03468231
Treatments Being Tested
This study used (cTACE or DEB-TACE + FOLFOX scheme HAIC) combined with PD-1...
Status
Unknown
Location
Multiple Locations
Start Date
2021-04
Trial ID
NCT04479527
Treatments Being Tested
Hepatocellular carcinoma (HCC) is one of the most commonly malignant tumors...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2013-10
Trial ID
NCT01997957
Treatments Being Tested
To study if the addition of HAIC following complete removal of early stage ...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2015-02
Trial ID
NCT02767375
Treatments Being Tested
This is a prospective, Two-arm, randomized，phase II clinical study of Sinti...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2022-08-23
Trial ID
NCT05519410
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of hepatic...
Status
Unknown
Location
Cancer Center Sun Yat-sen University
Start Date
2018-08-04
Trial ID
NCT03812770
Treatments Being Tested
A randomized trial showed that sorafenib plus hepatic artery infusion of 85...
Status
Unknown
Location
Cancer Center Sun Yat-sen University
Start Date
2020-12-30
Trial ID
NCT04687163
Treatments Being Tested
Tislelizumab is an anti-PD-1 monoclonal antibody with high binding affinity...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2023-05-30
Trial ID
NCT05877001
Treatments Being Tested